Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 24% ± 8% | |
natural killer cell | 3 studies | 20% ± 4% |
Insufficient scRNA-seq data for expression of CDC45 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 90% | 531.06 | 1633 / 1809 | 96% | 24.22 | 455 / 472 |
lung | 80% | 118.89 | 463 / 578 | 87% | 23.51 | 1001 / 1155 |
intestine | 56% | 149.60 | 544 / 966 | 96% | 23.13 | 507 / 527 |
stomach | 53% | 108.77 | 189 / 359 | 96% | 19.88 | 274 / 286 |
esophagus | 48% | 194.29 | 688 / 1445 | 98% | 20.99 | 180 / 183 |
bladder | 33% | 27.76 | 7 / 21 | 95% | 24.94 | 481 / 504 |
breast | 46% | 34.96 | 210 / 459 | 82% | 13.19 | 920 / 1118 |
uterus | 22% | 19.05 | 37 / 170 | 98% | 36.00 | 451 / 459 |
ovary | 14% | 17.93 | 26 / 180 | 90% | 12.11 | 387 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 43.84 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.11 | 1 / 1 |
spleen | 98% | 300.07 | 236 / 241 | 0% | 0 | 0 / 0 |
liver | 31% | 59.90 | 71 / 226 | 55% | 6.21 | 222 / 406 |
pancreas | 13% | 8.22 | 41 / 328 | 69% | 7.63 | 123 / 178 |
adrenal gland | 56% | 51.24 | 144 / 258 | 21% | 2.41 | 49 / 230 |
peripheral blood | 73% | 604.52 | 676 / 929 | 0% | 0 | 0 / 0 |
prostate | 51% | 41.41 | 125 / 245 | 21% | 1.59 | 107 / 502 |
thymus | 30% | 19.55 | 195 / 653 | 25% | 6.55 | 154 / 605 |
brain | 4% | 2.36 | 104 / 2642 | 44% | 7.12 | 311 / 705 |
adipose | 45% | 35.58 | 544 / 1204 | 0% | 0 | 0 / 0 |
kidney | 28% | 37.29 | 25 / 89 | 17% | 1.32 | 153 / 901 |
eye | 0% | 0 | 0 / 0 | 26% | 1.48 | 21 / 80 |
blood vessel | 24% | 15.94 | 315 / 1335 | 0% | 0 | 0 / 0 |
heart | 17% | 12.89 | 147 / 861 | 0% | 0 | 0 / 0 |
muscle | 8% | 4.14 | 64 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000727 | Biological process | double-strand break repair via break-induced replication |
GO_1902977 | Biological process | mitotic DNA replication preinitiation complex assembly |
GO_0006268 | Biological process | DNA unwinding involved in DNA replication |
GO_0006270 | Biological process | DNA replication initiation |
GO_0000076 | Biological process | DNA replication checkpoint signaling |
GO_0005813 | Cellular component | centrosome |
GO_0071162 | Cellular component | CMG complex |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031261 | Cellular component | DNA replication preinitiation complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003688 | Molecular function | DNA replication origin binding |
Gene name | CDC45 |
Protein name | Cell division control protein 45 homolog (PORC-PI-1) Cell division cycle 45 |
Synonyms | CDC45L2 UNQ374/PRO710 CDC45L |
Description | FUNCTION: Required for initiation of chromosomal DNA replication. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built. . |
Accessions | ENST00000438587.6 ENST00000455750.6 A0A5F9ZH29 ENST00000407835.6 ENST00000404724.7 [O75419-2] C9J911 O75419 ENST00000437685.6 [O75419-3] C9K087 H7BZ91 ENST00000672837.1 A0A5F9ZI22 ENST00000671972.1 ENST00000428937.1 ENST00000263201.7 [O75419-1] A0A5K1VW85 |